Signal Suite
Every Signal In Your Market. Delivered Before Your Competitors Know To Look.
Signal Suite is four recurring intelligence products built for life sciences commercial and BD teams. Each product is customized to your geography, therapeutic focus, company size, and BD priorities.
The organizations winning are not working harder. They are operating with better intelligence. Signal Suite puts your BD team into commercial conversations before competitors know the opportunity exists. Every product is customized to your market before a single entry is researched. Your specifications are applied as hard filters. Every entry in every edition meets your criteria.
Signal Suite
Four Recurring Intelligence Products.
Each product is customized to your geography, therapeutic focus, company size, and BD priorities.
Global Sponsor Intelligence
Trial Signal
The complete trial lifecycle intelligence product. Conference abstracts, ClinicalTrials.gov, funding events, partnering activity, all signal sources, one customized report.
The Trial Landscape Does Not Wait.
Learn More
Network Intelligence
LinkedIn Signal
Commercial intelligence applied to the network you already have. Every connection cross-referenced against all active Signal Suite signals in real time.
Someone In Your Network Is Ready To Move Right Now.
Learn More
Deal Flow Intelligence
Partnering Signal
Detects when companies enter alliances, collaborations, and partnerships before the market has a chance to respond.
Act Before The Partnership Is Public Knowledge.
Learn More
Capital Market Intelligence
Funding Signal
Translates funding closes into prioritized commercial triggers before the RFP is written or the trial announced.
Act On The Funding Signal Before The Market Sees The Trial.
Learn MoreHow It Works
How Signal Suite Works
Five steps from scan to BD-ready intelligence.
Scan
Your configuration applied across all geographies and signal sources. Geography, therapeutic focus, company size, trial phase, and regulatory jurisdiction. No entry outside your specification is included.
Qualify
Six ICP criteria applied. All six must be met. Non-qualifying companies excluded before a single word is written.
Research
Decision-maker verified. LinkedIn and contact intelligence gathered from public channels only. Conference presence mapped against your engagement calendar.
Score
Trial Readiness Score 1-10 assigned. Urgency band: Immediate. 6-12 Months. 12-24 Months.
Deliver
BD-ready report on agreed cadence. Day-one ready for your BD team. Your differentiators framed into every BD note.
Qualification
The Six ICP Criteria. All Six Must Be Met.
Non-qualifying companies are excluded before a single entry is researched.
Criterion 01
Global Scope
FDA, EMA, MHRA, TGA, Health Canada, or equivalent regulatory authority.
Criterion 02
Capital Event
Seed or Series A confirmed within prior 24 months.
Criterion 03
Lean Operating Model
Fewer than 15 employees. No internal clinical operations function.
Criterion 04
Trial Horizon
IND or CTA prep, or enrollment expected within 6 to 24 months.
Criterion 05
Named Decision-Maker
CEO, CMO, CSO, or VP Clinical Ops confirmed via public profile or press release.
Criterion 06
Focused Pipeline
1-3 programs with a clear lead asset and named indication.
Editions
Choose Your Cadence.
| Edition | What You Receive |
|---|---|
| Monthly | 10-15 entries per issue. Global financing from prior 30 days. Full profile, verified decision-maker, score, and engagement path. Best for CROs and SMOs with active BD pipelines. |
| Quarterly, recommended | 20-30 entries per issue. Full-quarter sweep. Trend analysis by therapeutic area, geography, and trial phase. Best for organizations with longer BD cycles. |
Edition Options, Monthly Vs Quarterly.
Therapeutic Filters, No Extra Cost
Commission Signal Suite
Start With The Intelligence.
Signal Suite is configured to your market before the first edition is built.